AI assistant
Thruvision Group PLC Remuneration Information 2022
7968_def-14a_2022-01-25_7270af96-dcaa-4d89-a95c-d772f729d103.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 6072Z
Thruvision Group PLC
25 January 2022
25 January 2022
Thruvision Group plc
("Thruvision" or the "Group")
Sharesave option grant to Executive Director
Thruvision (AIM:THRU), the leading provider of "safe distance" people-screening technology to the international security market announces a grant of share options under the Thruvision Sharesave Scheme (the "Scheme").
Earlier today the Remuneration Committee of the Group granted, under the rules of the Scheme, an option over 64,285 Ordinary 1p shares with an exercise price of 22.4 pence per share to Colin Evans (Chief Executive).
The exercise price, set on 30 December 2021, is calculated on the basis of 80% of the closing middle market price of Thruvision shares on 29 December 2021. The option may be exercised between 1 March 2025 and 31 August 2025, assuming the conditions of the Scheme are met.
Immediately prior to this grant, Colin Evans had 90,000 options under the scheme which have vested but have yet to be exercised at an option price of 20p.
The notifications below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail:
| 1. | Details of the person discharging managerial responsibilities/person closely associated | ||
| (a) | Name | Colin Evans | |
| 2. | Reason for the notification | ||
| (a) | Position/status | Chief Executive | |
| (b) | Initial notification/ Amendment | Initial notification | |
| 3. | Details of the issuer | ||
| (a) | Name | Thruvision Group plc | |
| (b) | LEI | 213800IZG9GM6G2TZE04 | |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| (a) | Description of the Financial Instrument | Ordinary shares of £0.01 each | |
| (b) | Identification code of the Financial Instrument | GB00B627R876 | |
| (c) | Nature of the transaction | Grant of Options under the Sharesave Scheme. | |
| (d) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 22.4p | 64,285 | ||
| (e) | Aggregated information - Aggregated volume - Price |
N/A | |
| (f) | Date of the transaction | 25 January 2022 | |
| (g) | Place of the transaction | Not a trading venue |
For further information please contact:
| Thruvision Group plc Colin Evans, Chief Executive Tom Black, Executive Chairman |
+44 (0)1235 425 400 |
| Investec Bank plc Patrick Robb / James Rudd / Sebastian Lawrence |
+44 (0)20 7597 5970 |
| FTI Consulting LLP Matt Dixon / Tom Blundell |
+44 (0)20 3727 1000 |
About Thruvision
Addressing the urgent need for "safe distance" people security screening in the COVID era, Thruvision is uniquely capable of detecting metallic and non-metallic items including weapons, explosives and contraband items that are hidden under clothing, at distances between 3 and 10m. Using patented passive terahertz technology, Thruvision completely removes the need for physical "pat-downs" and has been vetted and approved by the US Transportation Security Administration for surface transportation. Operationally deployed in 20 countries around the world, Thruvision is used for aviation security, retail supply chain loss prevention, customs and border control, and public area security. The company has offices near Oxford, and Washington DC.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBLGDBXGDDGDU